Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine (Q47976273)

7 February 2018

http://europepmc.org/abstract/MED/27447425

title

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine (English)

1 reference

7 February 2018

http://europepmc.org/abstract/MED/27447425

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Paolo Calabresi

series ordinal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

11

Hugo Vanderstichele

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

13

Lucilla Parnetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

10

Erik Stoops

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1

Davide Chiasserini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2

Leonardo Biscetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

3

Lucia Farotti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

5

Nicola Salvadori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

6

Viviana Lisetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

9

Giulia Frattini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

8

Elena Chipi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Francesca Baschieri

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

22 July 2016

1 reference

7 February 2018

http://europepmc.org/abstract/MED/27447425

published in

Journal of Alzheimer's Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

55-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

CSF biomarker variability in the Alzheimer's Association quality control program

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

pROC: an open-source package for R and S+ to analyze and compare ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Development and advanced validation of an optimized method for the quantitation of Aβ42 in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160298

21 January 2018

Identifiers

DOI

10.3233/JAD-160298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27447425%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference